![{[setting('site_name')]}](https://projxnews.com/uploads/setting/16983847711140531930.webp)
Veer Enterprises intends to build a new bulk medicines and intermediates plant in Dahej, Bharuch, Gujarat. The plant, which will produce bulk pharmaceuticals and intermediates for a variety of pharmaceutical goods, is planned to have a capacity of 1000 metric tons per year. The project is projected to cost roughly INR 7 crore and would be finished by 2024. Veer Enterprises is a pharmaceutical company that develops and manufactures bulk medicines and intermediates. The company has a great track record of invention and has created a number of proprietary technologies for bulk drug and intermediate production. Veer Enterprises' new plant in Dahej will be the company's second in India for bulk pharmaceuticals and intermediates.
The second factory is in Vadodara, Gujarat. Veer Enterprises' investment in the new Dahej plant is considerable, and it demonstrates the company's commitment to the Indian pharmaceutical business. The factory is projected to generate 100 new jobs and benefit the local economy.
Here are some of the key details of the project: Location: Dahej, Bharuch, Gujarat Capacity: 191 metric tons per annum Cost: INR 7 crores Completion date: 2024 Products to be manufactured: Bulk drugs and intermediates for a variety of pharmaceutical products Technology: Proprietary technologies developed by Veer Enterprises Jobs to be created: Around 100The project is still in the planning stage and is subject to regulatory approvals. However, Veer Enterprises is confident that the project will be completed on time and within budget.The new plant is expected to play a significant role in the growth of the Indian pharmaceutical industry and will help to make India a global hub for the manufacturing of bulk drugs and intermediates.
As of September 2023, The project is now in the stage of construction being started the work on the project will be finished in 2024, 2025 or 2026 It has been decided to hire a local contractor.
News by Rahul Yeligetti
